The standards this desk is held to.

ODR, short for Optimized Daily Report, is a daily industry brief for the people who run hormone, peptide, and GLP-1 clinics: prescribers, owners and operators, and the marketers who serve them. It covers regulation, enforcement, and the market, translated into what a clinic changes Monday. One email, weekday mornings.

It is business-to-business only. Nothing in it is addressed to patients or consumers, and nothing in it is medical or legal advice.

Primary sources, dated

Every regulatory fact carries the document date and a link to the primary document: Federal Register, FDA, DEA, state boards, court dockets. Law-firm analysis is cited as what it is, analysis, not the fact. Social posts and trade chatter are leads, never sources. If we can only source something secondhand, the item says so.

Confirmed, reported, and rumored never blur

Every claim in an issue carries one of three statuses, tagged inline where the claim appears, and statuses never share a sentence.

• CONFIRMED · a primary document exists, linked at the claim
• REPORTED · credible secondary sourcing, no primary document in hand; we name the source and say what would confirm it
• RUMORED · a circulating claim we cannot trace; we omit it, or cover the rumor itself as the story, labeled

A reported item that gets confirmed or falsified gets a follow-up line in a later issue. The loop closes in print, not quietly.

The conflations we refuse to make

• Advisory is not law. PCAC recommends; FDA decides through rulemaking. A vote changes nothing on the ground the next morning, and any item covering one says so.
• 503A is not 503B. Patient-specific compounding and outsourcing facilities are separate legal tracks with separate bulks lists. An item about one never implies the other.
• Category-2 removal is not permission to compound. Coming off a do-not-compound category is regulatory limbo, not a green light, and we never write it as one.
• Proposed is not final. A proposed rule, a comment period, a briefing document, a nomination: each is named as what it is, with the step that remains.

No medical advice, no consumer content

ODR covers the business and regulation of the industry. No dosing, no protocols, no efficacy claims. The subject is the reader's business, never anyone's body. Clinical and legal decisions belong with your medical director and your counsel.

ODR is an independent desk. No association, no vendor, no pharmacy, no manufacturer, and no clinic owns it, and none has a say in what it covers. Where the lawyers are the deeper source, we cite them by name and send you there.

Sponsorship, when it runs, is confined to fenced picks-and-shovels categories: clinic software, labs, compliance and malpractice insurance, patient financing, and professional education. Every placement is labeled, sponsors see nothing before publication, a sponsor in the news gets covered like a non-sponsor, same day, and gray-market vendor money is refused at any price. If ODR or its owners ever hold an interest in a covered company, the item says so at the top.